glp-1 asthma initiation was associated with a 14.6% reduced risk of exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients without diabetes, according to new research being Glucagon‐like peptide‐1 receptor agonist inhibits

Description

Patients who underwent a sleeve gastrectomy or gastric bypass lost about five times more weight after two years than people who had weekly injections of semaglutide or tirzepatide (the active ingredients in the anti-obesity drugs Wegovy and Zepbound, respectively), researchers reported Tuesday, June 17, at a meeting of the American Society for Metabolic and Bariatric Surgery

This is why the STEP trial protocol includes two intermediate doses (1.7 mg) before reaching 2.4 mg, and why many people find their sweet spot below maximum

My body, my hormones, were adjusting to my early forties just as I was experiencing pregnancy for the first, then second, time

If the outcome of this recent study can be confirmed, it could open up the possibility for medical practitioners, perhaps in liaison with the patients optometrist, to select an oral hypoglycaemic agent based on its effects on the anterior eye